Herbert Loong, MBBS, FASCO

We are learning from the best! @StephenVLiu on use of social media for thoracic oncology. #LCSM @IASLC Academy

Available @JTOonline - the 2024 @IASLC Global Survey on Biomarker Testing. Majority (67%) reported most patients had biomarker testing (up from 39% in 2018) but 43% sometimes treated before results. Barriers: cost, time, tissue, access, awareness. jto.org/article/S1556-…

#Honoured and #humbled to be back at @pmcancercentre @UHN @SarcomaToronto 🇨🇦 to meet old and new colleagues and friends. Thank you for coming in bright and early on a Friday morning for #GrandRounds 🎙️. Found my fellowship photo as well! 📸 #LCSM @CUHKMedicine #CUHKSarcoma

🎉Bravo to #RMPatPM's Dr. Philip Wong @DKirschMDPhD and team on their @CIHR_IRSC funded project: HARMONY, Hypofractionated Alternative Radiation with MOdulation of Neoadjuvant/perioperative immunotherapY in Sarcoma, which is pushing the boundaries of sarcoma treatment

🇭🇰🚝✈️🇨🇦🚗🏥=🤩 Looking forward to #returning to #Toronto and my alma mater @pmcancercentre for a short visit this weekend! Very honoured and privileged to be able to give #GrandRounds 🎙️ Best way to fight jet lag! Friends and colleagues - see you all soon! 👋 #LCSM #Sarcoma…

Recovering from #exhausting but #ExtremelyFruitful 4 days of conferences & meetings: @myESMO #AdvancedCourseInEarlyDevelopment and #ESMOTATAsia25 in #hongkong. 4 talks. 4 chairs. We are thrilled to have been host this #inaugural mtg bringing in > 600attendees from across the 🌎…

A Multi-Agent AI-Assisted System Designed for Clinical Trials Matching - Herbert Loong @herbloong @CodexGenetics oncodaily.com/blog/herbert-l… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews

🙏 @myESMO Great talks in our session on trial reporting in precision era: 🤩careful biomarker planning from get-go 🤩P1/2 PROMS! 🤩data visualisation crucial for engagement 🕷️🌋 🤩collab collab collab Team @herbloong x El Helali x Lim 🤩

Thanks #ToshioShimizu for flying the @apoddc flag high at #ESMOTATAsia25! 😃

Amazing work presented by @pankajpanda86 led by @TiraTanChia of @dukenus on behalf of @apoddc! So happy to see how #international #collaborations of like-minded #stakeholders can generate meaningful and impactful data. 📈📊🧑‍💻 Thanks everyone for your support!

Prof @AyaHelali -precautions/pitfalls in reporting exploratory biomarker analyses (No single guideline addresses this); Prof @herbloong increasing importance of PROs in early phase clin trials incl dose esc decisions-it’s complicated! #ESMOTATAsia25 @myESMO

Phase 1 trial of SHR-A1904 (CLDN18.2 TOPO1i ADC) in patients with G/GEJ cancer published on @NatureMedicine. Threshold of CLDN18.2 expression required for responses (similar to other CLDN18.2 ADCs)! Better safety at 6.0 mg/kg Q3W (recommended dose) than 8 mg/kg.

🙌 Welcome to #ESMOTATAsia25! The Congress kicks off today — get ready for cutting-edge insights in targeted therapies and early drug development. 👉 Join us to accelerate novel cancer therapeutics across the APAC region: #Oncology #CancerResearch 🔗 ow.ly/6pW250Woc2Z

#DoseEscalationMeeting of #multinational 🦘🇨🇦🇪🇸🇨🇭🇭🇰 #foodeffect 🍜🥢☕️🫖 cohort 😊. In person meetings trumps #zoom calls! #ESMOTATAsia25 #HongKong @myESMO #Phase1 #drugdevelopment #WeMissYouTimYap😂

Thrilled to be able to welcome my ‘partner-in-crime’ @danieltanmd from @dukenus #Singapore and his research colleagues from @SingHealthSG #NCCS to our #P1CTC, #CCTU of @CUHKMedicine in Hong Kong 🇭🇰. Also a quick visit to #CUHKMedicalCentre 😃 @apoddc @APCLC_2023 @StephenLChan1

Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

Starting the @myESMO #advancedcourse in #earlydrugdevelopment in #hongkong with our #supermentor Prof @lillian_siu @AACRPres @pmcancercentre highlighting the successes and lessons learned from phase 1 trials.

We are about to #kickoff the @myESMO #AdvancedCourse in #DrugDevelopment in #HongKong 🇭🇰 before the start of #ESMOTATAsia25! Wonderful weather to help spice up our discussions indoors 😃 @danieltanmd @apoddc @CUHKMedicine @lilliansiu1 @ttawasapon @DrHongchengZhu #PJVoon and…

Putting final touches together to my talk😀. Looking forward to welcoming you all to #hongkong 🇭🇰 for #ESMOTATAsia25! Don't be shy - come by and say hi! #drugdevelopment @CUHKMedicine @apoddc @APCLC_2023

#PublicEducation on #sarcomas can be fun! 😃 #facialkexpressions #CannotHideHit #HappyMonday #CUHKSarcoma youtu.be/XesQlcQPMOY?si…